ANGO Insider Transactions
212 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 1–100; provenance stays internal.
ANGO insiders transaction timeline
PurchaseSale
| Insider profile | Role | Date | Transaction | Shares | Price |
|---|---|---|---|---|---|
| Nighan Warren JR | SVP Quality and Regulatory | 2026-07-30 | Sale | 23,370 | $14.72 |
| Weiss Lawrence T | SVP, Chief Legal Officer | 2025-10-21 | Purchase | 10,000.0 | $11.81 |
| Trowbridge Stephen A | EVP and CFO | 2025-10-13 | Purchase | 890.0 | $11.16 |
| Clemmer James C | President and CEO | 2025-10-09 | Purchase | 10,000.0 | $11.15 |
| Nighan Warren JR | SVP Quality and Regulatory | 2025-01-16 | Sale | 4,060.0 | $12.31 |
| Nighan Warren JR | SVP Quality and Regulatory | 2024-10-10 | Purchase | 100.0 | $6.08 |
| Trowbridge Stephen A | EVP and CFO | 2024-10-08 | Purchase | 1,700.0 | $5.86 |
| Nighan Warren JR | SVP Quality and Regulatory | 2024-10-07 | Purchase | 768.0 | $6.09 |
| Clemmer James C | President and CEO | 2024-10-07 | Purchase | 20,000.0 | $6.03 |
| Clemmer James C | President and CEO | 2024-04-08 | Purchase | 10,000.0 | $6.7 |
| Helsel Dave | SVP Global Operations and R&D | 2023-01-31 | Sale | 4,633.0 | $12.95 |
| Trowbridge Stephen A | EVP and CFO | 2022-10-12 | Purchase | 1,083.0 | $13.82 |
| Clemmer James C | President and CEO | 2022-10-10 | Purchase | 10,000.0 | $15.0 |
| Helsel Dave | SVP Global Operations and R&D | 2022-07-29 | Sale | 5,000.0 | $22.44 |
| Helsel Dave | SVP Global Operations and R&D | 2022-04-28 | Sale | 3,513.0 | $22.44 |
| JOHNSON WESLEY | Director | 2022-04-12 | Sale | 1,299.0 | $23.26 |
| JOHNSON WESLEY | Director | 2022-04-11 | Sale | 6,201.0 | $23.0 |
| Trowbridge Stephen A | EVP and CFO | 2022-01-12 | Purchase | 1,000.0 | $22.64 |
| Clemmer James C | President and CEO | 2022-01-11 | Purchase | 10,000.0 | $22.84 |
| Helsel Dave | SVP Global Operations and R&D | 2021-10-20 | Sale | 3,494.0 | $27.97 |
| Centea Scott | Sr. VP/GM, Global VIT | 2021-10-15 | Sale | 12,000.0 | $27.92 |
| Campbell Chad Thomas | SVP/GM, Vascular Access | 2021-10-05 | Sale | 10,748.0 | $27.15 |
| Helsel Dave | SVP Global Operations and R&D | 2021-04-14 | Sale | 3,500.0 | $23.93 |
| JOHNSON WESLEY | Director | 2021-01-20 | Sale | 6,500.0 | $18.53 |
| Trowbridge Stephen A | EVP and CFO | 2020-08-11 | Purchase | 1,013.0 | $9.38 |
| Clemmer James C | President and CEO | 2020-07-31 | Purchase | 40,000.0 | $8.26 |
| Clemmer James C | President and CEO | 2019-10-25 | Purchase | 15,000.0 | $14.19 |
| Gould Kevin J | Director | 2019-07-16 | Sale | 13,650.0 | $21.45 |
| Greiner Michael | EVP and CFO | 2018-11-07 | Sale | 1,939.0 | $21.53 |
| Richard Stark | SVP, GM - Oncology | 2017-11-15 | Sale | 27,409.0 | $16.29 |
| REED JAN STERN | Director | 2017-07-24 | Purchase | 316.0 | $16.0 |
| DONNELLY HOWARD W | Director | 2017-07-21 | Purchase | 5,000.0 | $15.72 |
| Clemmer James C | President and CEO | 2017-07-21 | Purchase | 5,000.0 | $15.79 |
| Clemmer James C | President and CEO | 2017-07-20 | Purchase | 20,000.0 | $15.64 |
| Burgstahler David F | Director,TenPercentOwner | 2017-04-12 | Sale | 384,184.0 | $16.0 |
| Burgstahler David F | Director,TenPercentOwner | 2017-04-12 | Sale | 508,869.0 | $16.0 |
| Burgstahler David F | Director,TenPercentOwner | 2017-04-12 | Sale | 1,456,947.0 | $16.0 |
| Avista Capital Partners (Offshore), L.P. | TenPercentOwner | 2017-04-12 | Sale | 384,184.0 | $16.0 |
| Avista Capital Partners, L.P. | TenPercentOwner | 2017-04-12 | Sale | 384,184.0 | $16.0 |
| Avista Capital Partners GP, LLC | TenPercentOwner | 2017-04-12 | Sale | 384,184.0 | $16.0 |
| Navilyst Medical Co-Invest, LLC | TenPercentOwner | 2017-04-12 | Sale | 384,184.0 | $16.0 |
| Avista Capital Partners (Offshore), L.P. | TenPercentOwner | 2017-04-12 | Sale | 508,869.0 | $16.0 |
| Avista Capital Partners, L.P. | TenPercentOwner | 2017-04-12 | Sale | 508,869.0 | $16.0 |
| Avista Capital Partners GP, LLC | TenPercentOwner | 2017-04-12 | Sale | 508,869.0 | $16.0 |
| Navilyst Medical Co-Invest, LLC | TenPercentOwner | 2017-04-12 | Sale | 508,869.0 | $16.0 |
| Avista Capital Partners (Offshore), L.P. | TenPercentOwner | 2017-04-12 | Sale | 1,456,947.0 | $16.0 |
| Avista Capital Partners, L.P. | TenPercentOwner | 2017-04-12 | Sale | 1,456,947.0 | $16.0 |
| Avista Capital Partners GP, LLC | TenPercentOwner | 2017-04-12 | Sale | 1,456,947.0 | $16.0 |
| Navilyst Medical Co-Invest, LLC | TenPercentOwner | 2017-04-12 | Sale | 1,456,947.0 | $16.0 |
| Burgstahler David F | Director,TenPercentOwner | 2016-11-18 | Sale | 541,349.0 | $15.68 |
| Burgstahler David F | Director,TenPercentOwner | 2016-11-18 | Sale | 1,549,945.0 | $15.68 |
| Avista Capital Partners (Offshore), L.P. | TenPercentOwner | 2016-11-18 | Sale | 541,349.0 | $15.68 |
| Avista Capital Partners, L.P. | TenPercentOwner | 2016-11-18 | Sale | 541,349.0 | $15.68 |
| Avista Capital Partners GP, LLC | TenPercentOwner | 2016-11-18 | Sale | 541,349.0 | $15.68 |
| Navilyst Medical Co-Invest, LLC | TenPercentOwner | 2016-11-18 | Sale | 541,349.0 | $15.68 |
| Avista Capital Partners (Offshore), L.P. | TenPercentOwner | 2016-11-18 | Sale | 1,549,945.0 | $15.68 |
| Avista Capital Partners, L.P. | TenPercentOwner | 2016-11-18 | Sale | 1,549,945.0 | $15.68 |
| Avista Capital Partners GP, LLC | TenPercentOwner | 2016-11-18 | Sale | 1,549,945.0 | $15.68 |
| Navilyst Medical Co-Invest, LLC | TenPercentOwner | 2016-11-18 | Sale | 1,549,945.0 | $15.68 |
| Burgstahler David F | Director,TenPercentOwner | 2016-08-05 | Sale | 487,214.0 | $14.62 |
| Burgstahler David F | Director,TenPercentOwner | 2016-08-05 | Sale | 367,836.0 | $14.62 |
| Burgstahler David F | Director,TenPercentOwner | 2016-08-05 | Sale | 1,394,950.0 | $14.62 |
| Avista Capital Partners (Offshore), L.P. | TenPercentOwner | 2016-08-05 | Sale | 478,214.0 | $14.62 |
| Avista Capital Partners, L.P. | TenPercentOwner | 2016-08-05 | Sale | 478,214.0 | $14.62 |
| Avista Capital Partners GP, LLC | TenPercentOwner | 2016-08-05 | Sale | 478,214.0 | $14.62 |
| Navilyst Medical Co-Invest, LLC | TenPercentOwner | 2016-08-05 | Sale | 478,214.0 | $14.62 |
| Avista Capital Partners (Offshore), L.P. | TenPercentOwner | 2016-08-05 | Sale | 367,836.0 | $14.62 |
| Avista Capital Partners, L.P. | TenPercentOwner | 2016-08-05 | Sale | 367,836.0 | $14.62 |
| Avista Capital Partners GP, LLC | TenPercentOwner | 2016-08-05 | Sale | 367,836.0 | $14.62 |
| Navilyst Medical Co-Invest, LLC | TenPercentOwner | 2016-08-05 | Sale | 367,836.0 | $14.62 |
| Avista Capital Partners (Offshore), L.P. | TenPercentOwner | 2016-08-05 | Sale | 1,394,950.0 | $14.62 |
| Avista Capital Partners, L.P. | TenPercentOwner | 2016-08-05 | Sale | 1,394,950.0 | $14.62 |
| Avista Capital Partners GP, LLC | TenPercentOwner | 2016-08-05 | Sale | 1,394,950.0 | $14.62 |
| Navilyst Medical Co-Invest, LLC | TenPercentOwner | 2016-08-05 | Sale | 1,394,950.0 | $14.62 |
| Greiner Charles R | VP - Global Franchise | 2016-05-06 | Sale | 3,508.0 | $12.31 |
| Trowbridge Stephen A | SVP and General Counsel | 2016-04-25 | Sale | 2,440.0 | $12.18 |
| Trowbridge Stephen A | SVP and General Counsel | 2016-04-21 | Sale | 10,500.0 | $12.33 |
| Richard Stark | SVP, GM - Oncology | 2015-02-13 | Sale | 18,100.0 | $18.53 |
| Greiner Charles R | VP - Global Franchise | 2014-10-20 | Sale | 3,298.0 | $15.63 |
| Kapusta Matthew C | SVP, Business Development | 2014-04-14 | Purchase | 1,000.0 | $13.9 |
| Greiner Charles R | VP - Global Finance | 2013-11-14 | Sale | 4,373.0 | $15.46 |
| Greiner Charles R | VP - Global Finance | 2013-11-13 | Sale | 2,392.0 | $15.4 |
| BUCCI VINCENT | Director | 2013-10-18 | Purchase | 5,000.0 | $15.2 |
| DONNELLY HOWARD W | Director | 2013-10-17 | Sale | 20,000.0 | $15.06 |
| Gould Kevin J | Director | 2013-07-22 | Purchase | 2,700.0 | $12.0 |
| Greiner Charles R | VP - Global Franchise | 2013-05-09 | Sale | 1,495.0 | $10.38 |
| BUCCI VINCENT | Director | 2013-03-12 | Purchase | 10,000.0 | $10.8 |
| BUCCI VINCENT | Director | 2013-03-12 | Purchase | 35,000.0 | $10.76 |
| BUCCI VINCENT | Director | 2013-03-12 | Purchase | 40,000.0 | $10.78 |
| Meteny Dennis S | Director | 2013-03-12 | Purchase | 4,600.0 | $10.82 |
| BUCCI VINCENT | Director | 2013-02-14 | Purchase | 2,000.0 | $12.17 |
| Gould Kevin J | Director | 2013-01-11 | Purchase | 2,700.0 | $11.58 |
| GOLD JEFFREY | Director | 2012-11-05 | Purchase | 1,000.0 | $10.56 |
| Richard Stark | SVP, GM - Oncology | 2012-11-05 | Sale | 3,160.0 | $10.36 |
| DEVIVO JOSEPH | President and CEO | 2012-07-17 | Purchase | 2,000.0 | $11.67 |
| Richard Stark | SVP, GM - Oncology | 2012-05-16 | Sale | 2,080.0 | $12.42 |
| BUCCI VINCENT | Director | 2012-04-12 | Purchase | 2,000.0 | $11.87 |
| BUCCI VINCENT | Director | 2012-04-12 | Purchase | 4,000.0 | $11.82 |
| Gould Kevin J | Director | 2012-04-11 | Purchase | 2,700.0 | $11.72 |
| Kapusta Matthew C | SVP, Business Development | 2012-04-10 | Purchase | 1,000.0 | $11.4 |